Data related to the chemical part of the project: spectroscopic and spectrometric data for the structural elucidation of the molecules, as well as the spectrometric data of ceramide-type biomarkers

Read full text Summarise with VIRAT
Authors: Nuria Cabedo, Diego Cortés, Jordi Ferri Císcar, Carlos Villarroel-Vicente
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The dataset generated in this project consists of the spectra necessary for the structural elucidation of the synthesized molecules and ceramide-type molecules as biomarkers. It includes raw data and processed data for visualization. 1) NMR Spectra: Nuclear Magnetic Resonance (NMR) data. Includes: ¹H, ¹³C, DEPT, COSY, HSQC, HMBC, and other 2D experiments used in structural characterization. Formats: native spectrometer formats (Bruker/Varian directories), and/or processed data: FID files exported for analysis. Content: spectral signals, acquisition parameters, and instrumental metadata. 2) LC-MS Spectra: ESI-MS: raw data in .lcd format (Shimadzu), including complete spectra, relative intensities, instrumental parameters, and metadata. 3) LC-MS_Cer Spectra: UHPLC-mass spectrometry (MS) data relating to ceramides in mouse plasma. ESI-MS: Primary data in .lcd (Shimadzu) format, including full spectra, relative intensities, instrumental parameters, and metadata.

Fields of Study & Subjects

Sphingolipid Metabolism and Signaling Metabolomics and Mass Spectrometry Studies Mass Spectrometry Techniques and Applications

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 March 2026
Language
EN
Document type
Dataset